| Literature DB >> 23554554 |
Daniel Francisco Arencibia-Arrebola1, Luis Alfredo Rosario-Fernández, Yolanda Emilia Suárez-Fernández, Alexis Vidal-Novoa, Livan Delgado-Roche.
Abstract
The aim of this research was to compare the efficiency of different murine lines for genotoxicity assays. Rats and mice of different murine lines were used. The spontaneous and induced indexes were evaluated according to alkaline comet assay of peripheral blood leukocytes, micronucleus and chromosomic aberration assay of bone marrow cell, and sperm head morphology assay. In most of the evaluated assays the line of Balb/c mice turned out to be the ideal biomodel, with less spontaneous indexes and high induced indexes to the mutagen used; allowing to detect in a narrow error margin those substances that are classified of very low genotoxicity. These results demonstrate that genetically the line of Balb/c mice in both sexes is more stable than the other ones evaluated. This suggests the use of the Balb/c line on in vivo genotoxicity assay will increase sensibility and robustness.Entities:
Keywords: efficiency; genetic toxicology; genotoxicity; mice; murine lines; rats
Year: 2012 PMID: 23554554 PMCID: PMC3600514 DOI: 10.2478/v10102-012-0023-4
Source DB: PubMed Journal: Interdiscip Toxicol ISSN: 1337-6853
Comparison between Balb/c mice and Sprague Dawley rats of both sexes subjected to the comet assay, according to induction of DNA damage of peripheral blood leukocytes.
| Groups | Sex | Arbitrary Units | Level 0 | Level 1 | Level 2 | Level 3 | Level 4 |
|---|---|---|---|---|---|---|---|
| (Nucleoids %) | |||||||
|
| |||||||
| Negative Control | F | 49.51±10.24 | 56.00±8.01 | 39.29±7.49 | 4.01±4.17 | 0.60±0.68 | 0.10±0.05 |
| M | 56.37±7.51 | 51.03±3.14 | 42.72±5.68 | 5.10±2.77 | 1.15±1.05 | 0.00±0.00 | |
| Vehicle Substance 1 | F | 57.23±10.20 | 50.82±9.32 | 42.13±2.22 | 6.05±5.28 | 1.00±0.93 | 0.00±0.00 |
| M | 54.25±8.90 | 55.50±9.01 | 36.15±3.58 | 7.00±4.66 | 1.30±1.45 | 0.05±0.03 | |
| Vehicle Substance 2 | F | 52.15±10.31 | 57.47±3.76 | 34.27±8.58 | 6.90±4.50 | 1.36±0.46 | 0.00±0.00 |
| M | 56.33±7.62 | 49.97±10.03 | 44.92±2.02 | 4.00±5.76 | 1.03±0.49 | 0.08±0.02 | |
| Positive Control (CF) | F | 118.02±13.28 | 23.33±5.22 | 53.02±10.64 | 10.41±4.99 | 8.78±3.90 | 4.46±1.43 |
| M | 112.69±14.11 | 25.80±3.41 | 52.78±11.98 | 9.37±1.90 | 7.03±2.01 | 5.02±0.91 | |
|
| |||||||
| Negative Control | F | 34.80±10.24a | 79.14±4.32a | 11.86±5.02a | 5.37±3.10a | 2.32±1.01a | 1.31±1.00a |
| M | 33.46±7.51a | 80.10±5.22a | 11.23±5.56a | 5.00±2.89 | 2.45±1.20 | 1.22±0.98a | |
| Vehicle Substance 1 | F | 32.56±10.20a | 80.32±7.83a | 11.11±4.28a | 5.25±2.99a | 2.33±1.73a | 0.99±0.34a |
| M | 35.03±8.90a | 78.21±9.10a | 13.19±4.77a | 4.98±2.33a | 2.60±1.26 | 1.02±0.83a | |
| Vehicle Substance 2 | F | 33.19±10.31a | 80.46±6.59a | 10.78±5.11a | 5.17±3.15a | 2.29±1.51 | 1.30±0.99a |
| M | 33.44±7.62a | 79.75±3.83a | 12.19±4.99a | 4.96±2.51 | 2.07±1.65 | 1.28±1.01a | |
| Positive Control (CF) | F | 101.45±13.28 | 35.56±3.55 | 43.47±3.44 | 10.31±3.91 | 6.08±2.80 | 4.78±2.46 |
| M | 106.83±14.11 | 32.76±4.88 | 44.67±4.77 | 10.56±3.68 | 7.00±2.00 | 5.01±2.51 | |
CF (cyclophosphamide)
Administration by i.p. route
p<0.05 (Comparison against the negative control in the same species, Mann Whitney U test).
a=p<0.05 (It differs when comparing among species keeping in mind the same variable in the same experimental group, Mann Whitney U test). (X mean; S.D. standard deviation, for the two analyzed series).
Comparison of the basal and induced frequency of micronucleus in erythrocytes of bone marrow between Balb/c mice and SD rats of both sexes.
| Group | n | PE/NE | MN-PE (%) | MN |
|---|---|---|---|---|
|
| ||||
| Male | ||||
| Negative Control | 10 | 1.18±0.01 | 0.16±0.03 | 23 |
| Vehicle Substance 1 | 10 | 1.16±0.04 | 0.18±0.04 | 26 |
| Vehicle Substance 2 | 10 | 1.19±0.05 | 0.18±0.04 | 25 |
| Positive Control (CF) | 10 | 0.87±0.03 | 1.82±0.89 | 258 |
| Female | ||||
| Negative Control | 10 | 1.15±0.05 | 0.13±0.04 | 19 |
| Vehicle Substance 1 | 10 | 1.17±0.02 | 0.14±0.07 | 20 |
| Vehicle Substance 2 | 10 | 1.19±0.04 | 0.17±0.08 | 24 |
| Positive Control (CF) | 10 | 0.85±0.02 | 1.65±0.77 | 233 |
|
| ||||
| Male | ||||
| Negative Control | 10 | 1.20±0.03 | 0.19±0.05 | 27 |
| Vehicle Substance 1 | 10 | 1.19±0.04 | 0.21±0.02 | 30 |
| Vehicle Substance 2 | 10 | 1.18±0.06 | 0.15±0.06 | 22 |
| Positive Control (CF)‡ | 10 | 0.90±0.03* | 1.68±0.92* | 241 |
| Female | ||||
| Negative Control | 10 | 1.19±0.06 | 0.22±0.01 | 32 |
| Vehicle Substance 1 | 10 | 1.21±0.02 | 0.20±0.02 | 29 |
| Vehicle Substance 2 | 10 | 1.18±0.04 | 0.17±0.05 | 25 |
| Positive Control (CF)‡ | 10 | 0.89±0.04 | 1.74±1.03 | 250 |
CF (cyclophosphamide).
Administration by i.p. route.
2000 cells/animal analysed
p<0.05 comparison with the control, ANOVA Test, X mean; S.D standard deviation, for the two analysed series. (DDetermination in 2 000 PE/animal, p<0.01 (comparison with the control, Chi Squared χ2 no parametric test, for the two analyzed series).
a=p<0.05 (It differs when comparing among species keeping in mind the same variable in the same experimental group, using the same statistic test).
Results of the comparison of the spontaneous and induced frequency of chromosomic aberrations in bone marrow between Balb/c mice and SD rats of both sexes.
| Groups | MI (%) | Cells with poliploidy | Gaps | Number of cells with aberrations |
|---|---|---|---|---|
|
| ||||
| Male | ||||
| Negative Control | 5.65±0.56 | 1 | 4 | 7 |
| cyclophosphamide (50 mg/kg, i.p) | 3.89±0.24 | 14 | 47 | 175 |
| Vehicle Substance 1 | 5.49±0.53 | 0 | 6 | 8 |
| Vehicle Substance 2 | 5.86±0.20 | 0 | 7 | 10 |
| Female | ||||
| Negative Control | 5.98±0.22 | 1 | 6 | 8a |
| cyclophosphamide (50 mg/kg, i.p) | 3.93±0.84 | 18 | 44 | 192 |
| Vehicle Substance 1 | 4.98±0.79 | 0 | 5 | 8 |
| Vehicle Substance 2 | 5.12±0.63 | 1 | 2 | 9 |
|
| ||||
| Male | ||||
| Negative Control | 4.93±0.09 | 2 | 6 | 17 |
| cyclophosphamide (50 mg/kg, i.p) | 3.58±0.43 | 23 | 62 | 220 |
| Vehicle Substance 1 | 5.12±0.18 | 2 | 7 | 18 |
| Vehicle Substance 2 | 5.29±0.25 | 3 | 4 | 23 |
| Female | ||||
| Negative Control | 4.81±0.10 | 1 | 5 | 18 |
| cyclophosphamide (50 mg/kg, i.p) | 3.40±0.26 | 28 | 69 | 246 |
| Vehicle Substance 1 | 4.97±0.21 | 3 | 8 | 19 |
| Vehicle Substance 2 | 5.19±0.32 | 1 | 6 | 20 |
X ± S.D., 10 000 total cells/group/serie for a total of 20 000 evaluated cells
p<0.05; ANOVA Test.
p<0.01
Chi Squared χ2 non parametric test. Comparison against negative control for both tests in the same species.
a=p<0.05 (It differs when comparing among species keeping in mind the same variable in the same experimental group, using the same statistic test).
Comparison between Balb/c mice and SD rats in the sperm head morphology assay and spermatic concentration in epididymis.
| Group | n | Normal | Abnormal | Amorphous | Bananas | Without Hook | Two Tails | Concentration |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| NC | 20 | 489.3±5.8a | 10.7±5.8a | 6.2±5.7a | 1.2±1.7a | 2.0±3.8a | 0.3±1.5a | 2.27±0.2a |
| VS1 | 20 | 483.2±8.3a | 16.8±5.9a | 12.0±1.6a | 1.7±0.3a | 2.6±3.1a | 0.5±0.9a | 2.24±0.2a |
| VS2 | 20 | 487.6±3.7a | 12.4±3.7a | 7.1±5.2a | 1.7±1.2a | 3.1±2.7a | 0.5±0.2a | 2.25±0.3a |
| CF | 20 | 399.5±12.3 | 100.5±6.3*a | 39.1±6.8 | 22.1±3.7 | 29.9±6.1* | 9.4±2.0 | 0.84±0.5*a |
|
| ||||||||
| NC | 20 | 460.4±19.4 | 39.6±10.4 | 14.3±4.3 | 10.4±8.2 | 13.7±6.8 | 1.2±0.7 | 2.18±0.5 |
| VS1 | 20 | 460.6±8.3 | 39.4±8.3 | 16.6±6.6 | 9.3±4.4 | 11.8±3.7 | 1.7±0.9 | 2.09±0.3 |
| VS2 | 20 | 455.3±17.5 | 44.7±13.5 | 18.4±3.8 | 11.4±7.9 | 12.6±6.1 | 2.3±1.7 | 1.97±0.2 |
| CF | 20 | 408.0±7.0 | 92.0±7.0 | 27.6±8.0 | 30.0±2.9 | 30.5±7.0 | 3.9±0.5 | 0.81±0.3 |
(NC: Negative Control, VS1: Vehicle Substance 1, VS2: Vehicle Substance 2, CF: Cyclophosphamide).
Administration by i.p. route, during five consecutive days. Determinations in 500 cells/animal.
p<0.05 (comparison with the negative control in the same species, ANOVA Test).
a=p<0.05 (It differs when comparing among species keeping in mind the same variable in the same experimental group, ANOVA Test). (X mean; S.D. standard deviation, for the two analysed series).